Clinical trial
Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of…
NCT00437307 · North Eastern German Society of Gynaecological Oncology, Other · Completed
Key facts
| NCT number | NCT00437307 |
|---|---|
| Title | Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse |
| Official title | Topotecan Plus Carboplatin im Vergleich Zur Standardtherapie (Paclitaxel Plus Carboplatin Oder Gemcitabin Plus Carboplatin) in Der Therapie Von Patientinnen Mit Platin-sensitivem Rezidivierten Epithelialen Ovarialkarzinom, Peritonealkarzinom Oder Tubenkarzinom |
| Acronym | HECTOR |
| Lead sponsor | North Eastern German Society of Gynaecological Oncology, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Topotecan |
| Enrollment | 550 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2013 |
| Completion | Jun 1, 2015 |
| First posted | Feb 21, 2007 |
| Last update posted | Sep 22, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: